SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Lyondell Chemical Co – ‘S-8’ on 11/30/04 – EX-24

On:  Tuesday, 11/30/04, at 5:24pm ET   ·   Effective:  11/30/04   ·   Accession #:  1193125-4-205389   ·   File #:  333-120877

Previous ‘S-8’:  ‘S-8’ on 5/5/03   ·   Next:  ‘S-8’ on 4/1/05   ·   Latest:  ‘S-8’ on 12/23/05

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/30/04  Lyondell Chemical Co              S-8        11/30/04   10:673K                                   RR Donnelley/FA

Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan   —   Form S-8
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration of Securities to be Offered to         HTML    123K 
                          Employees Pursuant to an Employee                      
                          Benefit Plan                                           
 2: EX-4.13     Millennium Chemicals Inc. Sharesave Scheme 1997     HTML     63K 
 3: EX-4.14     Millennium Inorganic Chemicals Ltd (Asia/Pacific)   HTML     27K 
                          Employee Share Acq Scheme                              
 4: EX-4.15     Fonds Commun De Placement D'Enterprise              HTML     59K 
                          "Millennium" (English Translation)                     
 5: EX-4.16     Share Purchase Plan                                 HTML     34K 
 6: EX-4.17     Millennium Inorganic Chemicals Share Incentive      HTML    194K 
                          Plan                                                   
 7: EX-5.1      Opinion of Kerry A. Galvin                          HTML     11K 
 8: EX-23.2     Consent of Pricewaterhousecoopers LLP (For          HTML     10K 
                          Lyondell Chemical Company)                             
 9: EX-23.3     Consent of Pricewaterhousecoopers LLP (For          HTML      8K 
                          Millennium Chemicals Inc.)                             
10: EX-24       Power of Attorney                                   HTML     17K 


EX-24   —   Power of Attorney


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Power of Attorney  

 

Exhibit 24.1

 

LYONDELL CHEMICAL COMPANY

 

POWER OF ATTORNEY

 

WHEREAS, Lyondell Chemical Company, a Delaware corporation (the ”Company”), intends to file with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”), a Registration Statement on Form S-8, together with any and all exhibits and other documents having relation to said Registration Statement (collectively, the “Registration Statement”), in connection with the Millennium Chemicals Inc. Long Term Stock Incentive Plan, Millennium Chemicals Inc. 2001 Omnibus Incentive Compensation Plan, the Millennium Chemicals Inc. Supplemental Savings and Investment Plan, the Millennium Chemicals Inc. Salary and Bonus Deferral Plan, the Millennium Savings and Investment Plan, the Millennium Chemicals Inc. Sharesave Scheme 1997, the Millennium Inorganic Chemicals Ltd (Asia/Pacific) Employee Share Acquisition Scheme, the Fonds Commun de Placement d’Entreprise “Millennium”, the Share Purchase Plan and the Millennium Inorganic Chemicals Share Incentive Plan.

 

NOW, THEREFORE, the undersigned, in his or her capacity as a director or officer, or both, as the case may be, of the Company, does hereby appoint Dan F. Smith, T.Kevin DeNicola, Charles L. Hall and Kerry A. Galvin, and each of them severally, his or her true and lawful attorneys or attorney with power to act with or without the others and with full power of substitution and resubstitution, to execute in his or her name, place and stead, in his or her capacity as a director or officer or both, as the case may be, of the Company, the Registration Statement and all instruments necessary or incidental in connection therewith, with such amendment or amendments thereto in each case as may be necessary or appropriate, together with any and all exhibits and other documents relating thereto as said attorneys or any of them shall deem necessary or incidental in connection therewith, and to file the same or cause the same to be filed with the Commission. Each of said attorneys shall have full power and authority to do and perform in the name and on behalf of the undersigned, in any and all capacities, every act whatsoever necessary or desirable to be done to the premises, as fully and to all intents and purposes as the undersigned might or could do in person, the undersigned hereby ratifying and approving the acts of said attorneys and each of them.

 

IN WITNESS WHEREOF, the undersigned has executed this instrument effective as of the 30th day of November, 2004.

 

Signature


  

Title


/s/    DAN F. SMITH        


Dan F. Smith

  

President, Chief Executive Officer and Director

/s/    T. KEVIN DENICOLA        


T. Kevin DeNicola

  

Senior Vice President and Chief Financial Officer

/s/    KERRY A. GALVIN        


Kerry A. Galvin

  

Senior Vice President, General Counsel and Secretary

/s/    CHARLES L. HALL        


Charles L. Hall

  

Vice President and Controller

 


Signature


  

Title


/s/    DR. WILLIAM T. BUTLER        


Dr. William T. Butler

  

Chairman and Director

/s/    CAROL A. ANDERSON        


Carol A. Anderson

  

Director

/s/    STEPHEN CHAZEN        


Stephen Chazen

  

Director

/s/    TRAVIS ENGEN        


Travis Engen

  

Director

/s/    DANNY W. HUFF        


Danny W. Huff

  

Director

/s/    DR. RAY IRANI        


Dr. Ray Irani

  

Director

/s/    DAVID J. LESAR        


David J. Lesar

  

Director

/s/    STEPHEN F. HINCHLIFFE, JR.        


Stephen F. Hinchliffe, Jr.

  

Director

/s/    DUDLEY C. MECUM        


Dudley C. Mecum

  

Director

/s/    DR. WILLIAM R. SPIVEY        


Dr. William R. Spivey

  

Director

 

Top
Filing Submission 0001193125-04-205389   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 7:44:57.1pm ET